Connect with us

Press Release

HPD’s Dr. RAMI Unveils “Transformer Pro,” Declares Breakthrough in AI Efficiency and Capability the Linux of LLM

Published

on

United States, 4th Feb 2025 – In a bold challenge to China’s AI establishment, Dr. RAMI, founder of the UAE-based tech innovator HPD, today launched the HPD-Transformer Pro, a next-generation AI model he claims “rewrites the rules of intelligent systems” by outperforming DeepSeek’s flagship V3 model while slashing operational costs by 40%.

The release, timed to coincide with the Lunar New Year—a period when China’s tech giants traditionally halt operations—was framed by Dr. RAMI as a “strategic chess move” in Asia’s escalating AI arms race. “Where others see competition, They see evolution,” he told Reuters in an exclusive interview. “The HPD-Transformer isn’t just faster or cheaper—it’s architected to learn differently, merging structured logic with probabilistic intuition. This isn’t an upgrade—it’s a new species of AI.”

The announcement directly confronts DeepSeek, whose meteoric rise since the January 10 debut of its V3 model and R1 assistant has rattled global markets. But where DeepSeek sparked a price war with its ¥1-per-million-token rate, HPD undercut even that benchmark, pricing the Transformer Pro at ¥0.8 ($0.11) per million tokens—a figure Dr. RAMI called “the floor, not the ceiling, of what’s possible.”

 

 

A Vision Beyond “Brute-Force AI”

Critiquing the industry’s reliance on scale, Dr. RAMI emphasized HPD’s “hybrid-first” philosophy. “Today’s models are like gas-guzzling engines—powerful but wasteful,” he said. “The Transformer Pro operates like a quantum leap: its parsing modules dissect problems with surgical precision, while its density engines calculate uncertainty in real time. This isn’t just about answering questions—it’s about understanding them.”

The model’s architecture, he revealed, draws inspiration from neuroscience. “Human brains don’t brute-force data—they balance logic with intuition. They’ve replicated that duality. For instance, in medical diagnostics, the Transformer Pro doesn’t just predict outcomes—it maps why a 30% remission chance exists, layer by layer, while flagging gaps in the data.”

 

 

Disrupting the Giants

The launch intensifies pressure on Alibaba (9988.HK) and Tencent (0700.HK), which have scrambled to slash AI service prices by up to 97% since DeepSeek’s rise. But Dr. RAMI dismissed price wars as “distractions.” “Cutting costs is easy. Cutting-edge innovation isn’t. HPD isn’t here to play games—They’re here to build systems that outthink, not outspend.”

He contrasted HPD’s nimble, 200-person team—composed largely of MIT, Stanford, and Tsinghua graduates—with the “bloated hierarchies” of rivals. “Tech giants have committees. They have catalysts,” he said, noting that 70% of HPD’s staff are under 30. “AGI won’t be built by bureaucracies. It’ll be built by rebels.”

The AGI Gambit

While DeepSeek’s founder, Liang Wenfeng, has called AGI his “North Star,” Dr. RAMI framed HPD’s approach as radically distinct. “AGI isn’t a single model—it’s an ecosystem. The Transformer Pro is their first neuron in a decentralized brain. Within five years, they’ll deploy autonomous agents that collaborate, debate, and refine their code.”

When pressed on risks, he acknowledged concerns but argued stagnation is deadlier. “Yes, AGI is uncharted territory. But playing it safe? That’s how users end up a footnote. HPD would rather light a candle than curse the darkness—even if it burns fast.”

 

 

Market Shockwaves

The announcement sent ripples through Asian tech markets, with Alibaba’s shares dipping 2.3% in Hong Kong. Analysts warn HPD’s pricing could reset industry standards. “At ¥0.8 per million tokens, they’re not just competing—they’re redefining viability,” said TechAsia’s Li Wei.

Yet Dr. RAMI remains unfazed. “Let others chase benchmarks. they’re chasing horizons.” As fireworks lit Beijing’s skyline for the New Year, HPD seemed to mirror the occasion: a calculated risk, blazing bright against the unknown.

Amid the fanfare, Dr. RAMI revealed that the HPD-Transformer Pro’s public rollout will be delayed pending an extended training phase, for which he is actively courting global investors. “True innovation isn’t a sprint—it’s a marathon,” he stated. “They’re in talks with strategic partners to scale their training infrastructure, ensuring the model meets their zero-compromise thresholds for safety, creativity, and cross-domain mastery. This isn’t a delay—it’s a pledge. When they release it, the world will see why patience fuels perfection.”

HPD has already conducted extensive dataset testing, refining Transformer Pro’s architecture to ensure optimal performance across diverse applications. With its model and foundational framework firmly in place, HPD is now actively seeking investment to commercialize the technology at scale. Analysts speculate the move aims to secure $500M in funding to quintuple the model’s parameter count while maintaining its carbon-neutral training framework.

Key Innovations Highlighted:

  • Hybrid Neuro-Symbolic Architecture: Combines rule-based parsing with probabilistic reasoning.
  • Self-Auditing Density Layers: Flags low-confidence predictions in real time.
  • Decentralized Training: Leverages federated learning across 500+ global research partners.
  • Carbon-Neutral Compute: 100% solar-powered training clusters, cutting CO2 emissions by 80% vs. rivals.

“This is just Act I,” Dr. RAMI concluded. “The AI revolution isn’t coming—it’s here. And it speaks with their voice.”

Model link: https://www.linkedin.com/posts/ramishaheen_deepseek-newmodel-gai-activity-7291796053299789824-eTdQ?utm_source=share&utm_medium=member_android

Websitehttps://parse-and-visualize.lovable.app/auth

 

Media Contact

Organization: HPD-Transformer Pro

Contact Person: Dr. RAMI

Website: https://spiketransform.lovable.app/

Email: Send Email

Country: United States

Release Id: 04022523286

The post HPD’s Dr. RAMI Unveils “Transformer Pro,” Declares Breakthrough in AI Efficiency and Capability the Linux of LLM appeared on King Newswire. It is provided by a third-party content provider. King Newswire makes no warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Open Doors to the Asian Market: Seoul Bio Hub-Celltrion Launches ‘Global Open Innovation’ for U.S. Startups

Published

on

Seoul Bio Hub and Celltrion Launch Strategic Gateway ‘Global Open Innovation’ to Help U.S. Bio Startups Dominate the Asian Market

Two U.S.-Based Biotech and Medical Device Startups to Be Selected Based on Technology Alignment with Celltrion’s Expertise in Antibodies, Peptides, and Drug Formulation

Seoul, Korea – 17/09/2025 – (SeaPRwire) – Seoul’s bio startup hub ‘Seoul Bio Hub’ and global pharmaceutical leader ‘Celltrion’ have joined forces to launch the ‘2025 Seoul Bio Hub-Celltrion Global Open Innovation (GOI)’ program. This program goes beyond a simple competition, serving as a platform designed to help U.S. startups successfully establish themselves in the Asian market.

This GOI targets U.S.-based bio and medical startups, with companies established within the past 7 years eligible to apply. The recruitment areas encompass all technologies suitable for collaboration with Celltrion, including antibodies, peptides, small molecules, formulations, and cell and gene therapies.

The application deadline is September 30, 2025. The selection process will proceed in the following order:

  • Primary document evaluation
  • Technology review
  • Secondary presentation evaluation.

The two finally selected companies will receive customized follow-up support and gain opportunities to expand into global markets through collaboration with Celltrion, leveraging South Korea’s innovative ecosystem and global capabilities.

A Seoul Bio Hub representative stated, “This program will serve as a bridgehead that goes beyond simple space support, enabling U.S. startups to rapidly grow in the Asian market by leveraging Seoul’s excellent clinical infrastructure and research environment.”

A Celltrion representative announced, “Based on Celltrion’s capabilities and know-how accumulated across the entire pharmaceutical industry process including R&D, production, and sales, we will support promising U.S. startups to successfully enter the Asian market and create synergy with our company.”

South Korea has established itself as a bio hub leading the global market with clear numerical evidence. According to global consulting firm Intralink, South Korea’s biopharmaceutical market is valued at approximately $22 billion, ranking 13th globally.

Additionally, market research firm Grand View Research forecasts that South Korea’s biotechnology market will grow to $81.6 billion (approximately 110 trillion KRW) by 2030, representing an annual average growth rate of 18.3%.

Private investment is also active. From 2020 to 2022, R&D and facility investments recorded an annual average growth rate of 21.6%. This demonstrates that South Korea is not merely a potential market, but a rapidly growing innovation ecosystem.

According to ClinicalTrials.gov, the global clinical trial database, Seoul has consistently maintained a top position among major global cities in the number of new clinical trials over the past decade.

South Korea’s Ministry of Health and Welfare has set ‘Achieving Global 3rd Place in Clinical Trials’ as a policy objective through the ‘3rd Five-Year Plan for the Pharmaceutical and Bio Industry (2023-2027)’. Furthermore, in 2025, it raised a total of over 386.6 billion KRW through the ‘Bio Health Mega Fund’ and is actively supporting innovative companies’ clinical trials and commercialization through the national integrated bio big data construction project and AI, bio health regulatory regulatory sandboxes.

Seoul Bio Hub is a bio startup support organization established by Seoul City in 2017. It provides 251 pieces of shared laboratory equipment and affordable tenant space at 10% of the cost compared to major areas in Seoul. As of May 2025, it has supported 322 startups and attracted a total of 576 billion KRW in follow-up investment, proving its potential for success.

Celltrion is South Korea’s global comprehensive biotechnology company that developed the world’s first antibody biosimilar ‘Remsima’. The company performs the entire process from research and development to approval, production, and sales, supplying high-quality biopharmaceuticals to over 100 countries worldwide. Based on world-class research and production infrastructure, it contributes to expanding global access to pharmaceuticals and continues to support and collaborate with promising startups through active open innovation strategies.

For detailed information regarding program applications and inquiries, please access LinkedIn, search for ‘Seoul Bio Hub’, and check the 2025 Seoul Bio Hub-Celltrion Global Open Innovation recruitment announcement posted on the official company page.

About Seoul Bio Hub

https://www.seoulbiohub.kr/front/user/engmain.do

Establishment Date: October 30, 2017

Operating Entity: Established by Seoul City / Joint operation by KIST and Korea University

Location: 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, Republic of Korea

Purpose: Growth and commercialization support for early-stage bio and healthcare startups under 10 years

Tenant Companies (As of June 2025): Total 126 companies (Digital Health 42 companies (33.3%), Pharmaceuticals 61 companies (48.5%), Medical Devices 23 companies (18.2%))

Infrastructure: Laboratories, office spaces, meeting rooms, conference rooms, research equipment (249 devices, 109 types, approximately $8 million scale)

Research and Human Resource Network (Regional): Approximately 7,000 PhD-level personnel, approximately 120,000 university students, $1.13 billion in research funding, connections with 12 universities and research institutions and 7 hospitals

Major Support Programs:

  • IR matching and investment linkage
  • Expert consulting and CEO education
  • Hospital-linked clinical and data programs
  • Open innovation with domestic and international pharmaceutical companies

About Celltrion

https://www.celltrion.com/en-us

Establishment Date: February 26, 2002

Location (Headquarters): 23 Academy-ro, Yeonsu-gu, Incheon Metropolitan City, Republic of Korea

Business Areas and Major Products (Services)

Possessing Differentiated Integrated Solutions Across the Entire Biopharmaceutical Business Process

  • Remsima: World’s first monoclonal antibody biosimilar (TNF-α inhibitor)
  • Herzuma: Trastuzumab biosimilar for breast and gastric cancer treatment
  • Truxima (CT-P10): Rituximab biosimilar (lymphoma, rheumatoid arthritis, etc.)
  • Multiple products including Zymfentra, Yuflyma, Vegzelma, Steqeyma, Avtozma are under global approval and commercialization

No of Employees: Approx. 3,003 (As of June 30, 2025)

Media Contact

Brand: SEOUL BIO HUB

Contact: Lee Yoon Jin

Phone: +82 02-2200-3345

Email: lynj@kist.re.kr

Website: (KOR) https://www.seoulbiohub.kr/front/user/main.do;

(ENG) https://www.seoulbiohub.kr/front/user/engmain.do

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Hillman Unveils New-Generation Hunting Boots for Men Featuring Dual-Insulation Space-Grade Technology

Published

on

Boca Raton, FL, United States, 17th Sep 2025 – Hillman, the performance hunting brand trusted by professionals across rugged North American terrain, today announced the release of its next-generation line of hunting boots for men, engineered with a dual-insulation system inspired by space technology. The new hunting boots collection delivers arctic-level warmth at a fraction of the weight and bulk of traditional padded boots.

Purpose-built for early season to late winter, the collection centers on two flagship models: the Insulated Hunting Boots – Warmest Waterproof Aerogel and the Waterproof Hunting Boots – Uninsulated Lightweight DryHunt. Both are made to improve comfort, traction, durability, and thermoregulation for professional hunters who want more from their shoes.

Insulated Hunting Boots: Aerogel Warmth for Extreme Cold

Hillman’s Insulated Hunting Boots are built for the toughest late-season hunts. Rated for 22°F (−30°C), these boots use a dual insulation system that comes with the world’s lightest thermal layer.

Highlights include:

  • Apex Warmth: Up to 16× lighter and 30% less bulky than traditional Thinsulate boots.
  • Dryhunt nano-membrane: Blocks water up to 5 inches deep while pumping out sweat for all-day dryness.
  • Vibram ARCTIC GRIP outsole: Engineered for mud, snow, and ice traction.
  • The FREELOCK smart lacing system: 1 mm stainless steel wire that is almost impossible to break for quick and safe fit changes.
  • Comfort right out of the box: Ergonomic design gets rid of the break-in phase, so you can go for a long time without getting blisters or getting tired.

This insulated powerhouse changes the game for men’s hunting boots in very cold conditions.

Waterproof Hunting Boots: Lightweight Versatility for All Seasons

For early and mid-season hunts, Hillman introduces its ultralight waterproof model: the Waterproof Hunting Boots . Weighing just 1.1 lbs per boot, they deliver agility without sacrificing durability or waterproofing.

Key features include:

  • Dryhunt breathable waterproofing: 300% more air-permeable than standard membranes, preventing sweaty feet while keeping water out.
  • World-class insulation: A featherlight 1 mm layer keeps feet comfortable from 70°F down to 23°F.
  • Vibram MEGAGRIP outsole: Superior mud-shedding grip and quiet performance in diverse terrain.
  • FREELOCK lacing system: Fast on/off adjustments, reliable even in mud or grit.
  • Dyneema reinforcements: Unmatched strength for usage in all seasons.

Engineered for mobility, these waterproof hunting boots for men adapt seamlessly from warm September stalks to chilly November mornings.

The Next Evolution of Hunting Footwear

For decades, hunters have struggled with bulky, sweat-trapping boots that either compromise comfort or fail in extreme weather. Hunters can be safe down to −22°F (−30°C) without the hefty grams of insulation holding them down thanks to Aerogel insulation, which is up to 16 times lighter than regular padding. This new technology keeps you warm without adding bulk, beating even the thickest regular boots.

Hillman’s innovative Dryhunt membrane is at the heart of this new product. It allows for up to 300% more breathability than regular waterproof liners while yet keeping you completely dry. The end result is the best thermoregulation in all weather: dry comfort in the heat, steady warmth in the cold, and steady performance over lengthy hunts.

Why Hunters Choose Hillman

Hunters all across the world trust Hillman for clothes and shoes that can handle the roughest circumstances in the wild. The business has been making gear for hunters for decades, combining tradition, technology, and genuine hunting expertise to make gear that keeps hunters focused on the hunt instead of their pain.

“Hunters don’t compromise, and neither do we,” said the Hillman team. “Our hunting boots for men are built to protect against nature’s toughest elements while delivering comfort that feels broken-in from day one. It’s not just footwear; it’s an edge in the field.”

Shop the Collection Today

Hillman’s full line of hunting boots for men is available now, featuring both insulated and uninsulated designs built for every season. Hunters can shop with confidence thanks to free shipping on orders over $299, hassle-free returns, and a warranty against manufacturing defects.

Shop the full collection of hunting boots for men at https://hillmangear.com/collections/hunting-boots-men-s-hunt-footwear.

German customers can explore the Hunter’s boots collection on the German version of the website. 

Inquiries can be sent to cs@hillmanhunting.com.

Address: 2255 Glades Road, Boca Raton, FL 33431, United States.

About Hillman

Hillman designs advanced hunting apparel and footwear that merge cutting-edge materials science with decades of real-world field experience. From space-inspired insulation and nano-porous waterproof membranes to Vibram traction systems and Dyneema reinforcements, Hillman develops gear for hunters who demand comfort, durability, and performance in the harshest conditions.
 

Media Contact

Organization: Hillman Gear Ltd

Contact Person: Marry White

Website: https://hillmangear.com/collections/hunting-boots-men-s-hunt-footwear

Email: Send Email

City: Boca Raton

State: FL

Country:United States

Release id:33989

The post Hillman Unveils New-Generation Hunting Boots for Men Featuring Dual-Insulation Space-Grade Technology appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

YouLumi Launches IRP010 Series: Professional Red-Light Therapy Panels for Gyms, Clinics, and Wellness Centers

Published

on

China, 17th Sep 2025, – Professional photobiomodulation manufacturer YouLumi today announced the launch of its IRP010 Series red-light therapy solutions, designed for gyms, rehabilitation clinics, wellness centers, and medical-aesthetic facilities worldwide. The line spans compact mini devices to full-body systems, all engineered with dual-wavelength 660 nm and 850 nm LEDs delivering clinical-grade irradiance for fast, effective recovery.

YouLumi Launches IRP010 Series: Professional Red-Light Therapy Panels for Gyms, Clinics, and Wellness Centers

Standout Product Highlights

● YL-IRP-007MN Mini Panel – Portable yet powerful: delivers 140 mW/cm² at 3 inches, with dual-wavelength LEDs, rechargeable battery, and smart modes like Sleep, Pet, and Breathing. Ideal for quick recovery and skincare on the go.

● YL-IRP010-H06T (450 W Panel) – Equipped with 960 LEDs delivering >150 mW/cm², with versatile control options (touch, app, remote, voice). A professional yet accessible panel for daily wellness and gym recovery.

● YL-IRWS-022M Sleep Bag – Immersive full-body coverage with 2,632 LEDs (650/850 nm) and 225 W output. Features multiple intensity levels, pulse modes, and a zero EMF design. Tailored for deep relaxation, circulation, and post-exercise recovery, widely used in spas and at-home wellness routines.

● YL-IRP-004 Full-Body Panel – Available in 150–600 W configurations, delivering >135 mW/cm² at 6 inches. Covers pain relief, muscle repair, and skin rejuvenation, trusted by physiotherapists and wellness studios.

Other IRP010 series models, such as the IRP010-04T (300 W), IRP010-08T (600 W), IRP010-03L (900 W), IRP010-05L (1,600 W), and flagship IRP010-06L (1,700 W), complement the portfolio by offering scalable solutions for diverse wellness and clinical environments.

Application Scenarios

Setting Recommended Models Key Benefits
Home wellness 007MN / H06T Daily skincare, sleep improvement, relaxation
Fitness recovery H06T / IRP-004 10-minute recovery sessions between workouts
Physical therapy IRP-004 / 05L Support for arthritis and soft-tissue care
Clinical medicine IRWS-022M / 06L Deep-tissue therapy, post-surgical healing

YouLumi Launches IRP010 Series: Professional Red-Light Therapy Panels for Gyms, Clinics, and Wellness Centers

Executive & Customer Insights

Wu Solar, CEO of YouLumi:

“The IRP010 series reflects feedback from over 1,200 professional clients, balancing power and usability for busy commercial environments.”

Lisa Murray, VP of Operations, ReFit Fitness (USA):

“In pilot gyms, the IRP010-06L was reported to reduce average recovery time by up to 40%, improving member satisfaction and turnover.”

Market Outlook

● Allied Market Research projects a 14.6% CAGR for red-light therapy devices worldwide (2024–2030).

● Grand View Research valued the global photobiomodulation market at USD 240 million in 2022, expected to exceed USD 540 million by 2030.

● YouLumi has served 35 countries since 2018 with a 42% repeat-purchase rate.

Availability

All IRP010 models include a three-year full warranty and 24/7 technical support.

The series will debut at the Hong Kong International Lighting Fair – Autumn Edition 2025 (Booth 3D-B06).

Media representatives and business visitors are welcome to book a live demo and explore early-adopter incentives directly at the booth. For detailed specifications and demo bookings, visit Red light therapy panel, Rejuvenate Your Skin and Mind.or email sales@youlumi.com.

High-resolution images are available for media use upon request.

About YouLumi

Founded in 2012, YouLumi develops and manufactures red-light and professional LED devices. Operating a 3,000 m² factory in Shenzhen with two automated SMT/assembly lines, the company holds 40+ international patents and certifications, including ETL, CE, RoHS, and FDA 510(k). YouLumi has been a trusted supplier for over 1,200 professional clients across 35 countries, serving the fitness, rehabilitation, and aesthetics industries.

Media Contact

Organization: Shenzhen Youlumi Co., Ltd.

Contact
Person:
Youlumi

Website:

https://www.youlumistore.com/

Email:

sales@youlumi.com

Country:China

The post
YouLumi Launches IRP010 Series: Professional Red-Light Therapy Panels for Gyms, Clinics, and Wellness Centers
appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST